Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
/in Dendritic Cells, Hyperthermia, International Publications, IOZK VeröffentlichungenViro-immune therapy: A new strategy for treatment of pancreatic cancer
/in International Publications, Newcastle Disease Virus, Pancreatic CancerLong-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International PublicationsCurrent status and perspectives of immune-based therapies for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease VirusVitamin B6 Modifies the Immune Cross-Talk between Mononuclear and Colon Carcinoma Cells
/in International Publications, MicronutrientsEffective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
/in Dendritic Cells, International Publications, Malignant MelanomaNewcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
/in International Publications, Malignant Lymphoma, Newcastle Disease VirusOncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
/in International Publications, Newcastle Disease VirusIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer